Modest survival benefits have been reported in patients with acute myocardial infarction complicated by cardiogenic shock who were treated with early surgical revascularization or thrombolytic therapy. To determine whether coronary angioplasty improves survival, 87 patients with cardiogenic shock complicating acute myocardial infarction at the University of Michigan, Ann Arbor, Michigan, from 1975 to 1985 were retrospectively analyzed. Patients in group 1 (n= 59) were treated with conventional therapy; patients in group 2 (n=24) were treated with conventional therapy and angioplasty. Extent of coronary artery disease, infarct location, and incidence of multivessel disease were similar between groups. Hemodynamic variables including cardiac index, mean arterial pressure, and pulmonary capillary wedge pressure were also similar. The 30-day survival was significantly improved for group 2 patients (50% vs. 17%, p=0.006). Survival in group 2 patients with successful angioplasty was 77% (10 of 13 patients) versus 18% (two of 11 patients) in patients with unsuccessful angioplasty, (p=0.006). The findings suggest that angioplasty improves survival in cardiogenic shock compared with conventional therapy with survival contingent upon successful reperfusion of the infarct-related artery. (Circulation 1988;78:1345-1351 C ardiogenic shock remains a lethal complication of acute myocardial infarction. 
There were no differences between group 1 and group 2 with respect to age, gender, history of hypertension, previous myocardial infarction, angina, or coronary artery bypass grafting (Table  1) . Group I patients reported a higher usage of digoxin compared with group 2 patients (19% vs. 0%, p=0.02). Use of nitrates and 3-blockers before hospitalization was similar between groups. Both groups had a high incidence of anterior wall infarction. Lateral wall infarction occurred infrequently. Four patients in group 1 had indeterminate infarct locations secondary to the development of either a new left bundle branch block (two patients), or atrioventricular dissociation (two patients). Myocardial infarction, however, was confirmed by a rise in creatine kinase MB isoenzymes in these patients. Dopamine was instituted with equal frequency in both groups; l-norepinephrine, however, was used more frequently in group 1 patients (33% vs. 8%, p=0.05), whereas dobutamine was used significantly more often in group 2 patients (50% vs. 26%, p=0.05). Intra-aortic balloon counterpulsation was initiated in 31% of group 1 patients and 88% of group 2 patients (p=0.001). No patient in group 1 underwent coronary artery bypass surgery during the hospitalization, whereas four patients in group 2 underwent bypass graft surgery. Two patients underwent surgery immediately from the catheterization laboratory, one because of dissection of the left anterior descending artery and the other because of inability to cross the lesion. Both patients died. Peak creatine kinase MB isoenzyme activity was significantly higher in group 2 patients compared with group 1 patients (5,888 ±5,607 vs. 3,151 ±2,969 IU, p=0.01). Group 2 patients also demonstrated a tendency toward earlier peak of creatine kinase MB activity (16±12 vs. 30±32 hours, p=0.07). The duration of chest pain to development of cardiogenic shock was longer in group I patients (47±53 vs. 28+30 hours), but this difference was not statistically significant. In group 2 patients, angioplasty was attempted at 20± 32 hours after the onset of cardiogenic shock (range, 2-95 hours). In patients who had successful angioplasty (n= 13), 60% were reperfused within 12 hours of the onset of shock. Life-threatening arrhythmias documented by electrocardiogram occurred with high frequency in both groups. Ventricular tachycardia occurred in 51% of group 1 patients and 46% of group 2 patients. Cardioversion was required in 36% of group 1 patients and 38% of group 2 patients. Hemodynamic Data Hemodynamic variables obtained during cardiogenic shock were similar. No statistically significant differences were found with respect to heart rate, systolic blood pressure, right atrial pressure, pul- Decreased myocardial perfusion and progressive myocardial necrosis amplify the severity of the original lesion perpetuating the viscious cycle of the shock state.35-38 Standard drug therapy with sympathomimetic amines has not improved survival in cardiogenic shock. Although,-adrenergic agonists increase both the force and velocity of myocardial contraction, this positive inotropic effect is achieved at the expense of increased myocardial oxygen consumption.39-43 Mueller and colleagues44 demonstrated that isoproterenol improved total cardiac performance but caused a deterioration in myocardial cell metabolism despite an increase in coronary perfusion. Intra-aortic balloon counterpulsation for shock has produced little long-term benefit. Hagemeijer et a145 reported a 1-year mortality of 71% (15 of 21 patients died). This mortality is comparable to that reported by Chatterjee et al,46 who used pharmacological afterload reduction with intra-aortic balloon pump assistance.46 Scheidt and coworkers19 reported similar results in a controlled cooperative study; mortality at one year was 90% in 87 patients.
DeWood and associates26 first suggested that coronary reperfusion with emergent coronary bypass 
